-
Eric Drew posted an update in the group Hodgkin’s Lymphoma Advocate Network
There is a cure!
Hodgkins Lymphoma Game Over: Diane Paradise Beat the Odds (Part 2: #WeCanICan Series) • Save The Cord FoundationHodgkins Lymphoma Game Over: Meet Diane Paradise. Cancer survivor who chose Cord Blood over bone marrow transplant and chemotherapy (Part 2: #WeCanICan ).
-
Aarchi Advani joined the group Hodgkin’s Lymphoma Advocate Network
-
Sassy joined the group Hodgkin’s Lymphoma Advocate Network
-
Daniel Christian Patient Advocate joined the group Hodgkin’s Lymphoma Advocate Network
-
Eric Drew posted an update in the group Hodgkin’s Lymphoma Advocate Network
FDA expands approval of Adcetris for first-line treatment of Stage III or IV classical Hodgkin lymphoma in combination with chemotherapyFDA approves Adcetris (brentuximab vedotin) to treat adult patients with previously untreated stage III or IV classical Hodgkin lymphoma (cHL) in combination with chemotherapy -
Llbil5@aol.com joined the group Hodgkin’s Lymphoma Advocate Network
-
Willie Dawkins-Miller joined the group Hodgkin’s Lymphoma Advocate Network
-
Eric Drew posted an update in the group Hodgkin’s Lymphoma Advocate Network
There is a cure!
Hodgkins Lymphoma Game Over: Diane Paradise Beat the Odds (Part 2: #WeCanICan Series) • Save The Cord FoundationHodgkins Lymphoma Game Over: Meet Diane Paradise. Cancer survivor who chose Cord Blood over bone marrow transplant and chemotherapy (Part 2: #WeCanICan ). -
Eric Drew posted an update in the group Hodgkin’s Lymphoma Advocate Network
New drug approved! – http://www.medicalnewstoday.com/releases/311760.php
-
Eric Drew joined the group Hodgkin’s Lymphoma Advocate Network